Sunovion Pharmaceuticals Inc. recently announced the beginning of enrollment for its Phase 3 clinical trial plan for SUN-101 (glycopyrrolate) solution for inhalation to be delivered through the investigational eFlow®nebulizer system (SUN-101/eFlow®) from PARI Pharma GmbH. ... Read more